Endo Tools Therapeutics and Fujifilm Middle East FZE Partner to Extend Access to Innovative Treatments for Obesity

Partnership enables Fujifilm Middle East FZE to distribute Endo Tools Therapeutics’ groundbreaking endomina® product range across 18 countries in Middle East and Africa (MEA) Endo Tools Therapeutics’ minimally invasive platform provides novel endoscopic gastroplasty procedure for adults with obesity, a disease increasing in prevalence in MEA region GOSSELIES, Belgium & DUBAI, United Arab Emirates–(BUSINESS WIRE)–Endo … [Read more…]

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

ROCKVILLE, Md. & EDMONTON, Alberta–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it will host a webcast and conference call on June 30, 2025, at 8:30 a.m. ET to discuss AUR200 Phase 1 study results. The link to the webcast is available here. To join the conference call, please dial 877-407-9170/+1 201-493-6756. Click here … [Read more…]

Torrent Pharma to Acquire Controlling Stake in J. B. Chemicals & Pharmaceuticals from KKR

Acquisition to be followed by merger; strengthens Torrent’s IPM market presence MUMBAI, India–(BUSINESS WIRE)–Torrent Pharmaceuticals Limited (“Torrent”) and global investment firm KKR today announced that Torrent has entered into definitive agreements to acquire controlling stake in J. B. Chemicals and Pharmaceuticals (“JB Pharma”) from KKR at an Equity Valuation of INR 25,689 crores (on fully … [Read more…]

Mended Hearts International Foundation Will Be Launched to Empower Patients with Cardiovascular Diseases Worldwide

The Geneva-based Mended Hearts International Foundation will expand peer-to-peer support, education programs, and advocacy for healthcare policy changes. GENEVA–(BUSINESS WIRE)–For more than seven decades, patients with cardiovascular diseases have found hope through a simple but powerful concept: peer-to-peer support from those who have walked the same journey. Now, the mission of The Mended Hearts, Inc. … [Read more…]

SBC Medical added to membership of Russell 3000® Index

IRVINE, Calif.–(BUSINESS WIRE)–#Medical—SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. Membership in the Russell 3000® … [Read more…]

CAP: Improving Health Around the World, One Lab at a Time

NORTHFIELD, Ill.–(BUSINESS WIRE)–Reliable diagnostic testing is essential to good medical care, but many laboratories worldwide still face barriers to delivering consistent, high-quality results. To close that gap the College of American Pathologists (CAP) is working with hospitals to improve lab performance, bringing critical support where it’s needed most. Through its Laboratory Accreditation Program, the CAP … [Read more…]

ScienceSoft’s Gala Batsishcha Named Among Top 100 Women in Health IT for 2025

MCKINNEY, Texas–(BUSINESS WIRE)–#DigitalHealth–ScienceSoft is thrilled to announce that Gala Batsishcha, Senior Business Analyst and Healthcare IT Consultant at ScienceSoft, has been named one of the Top 100 Women in Health IT to Know in 2025 by Becker’s Hospital Review. This recognition celebrates Gala’s rare blend of clinical, pharmaceutical, and IT expertise, as well as her … [Read more…]

Bone Biologics Files Patent Application for Bone Regeneration Technology

BURLINGTON, Mass.–(BUSINESS WIRE)–$BBLG #Bonebiologics—Bone Biologics Corporation (“Bone Biologics” or the “Company) (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces the filing of a patent application with the United States Patent and Trademark Office (USPTO) for its novel NELL-1 protein. The patent application is directed to compositions of rhNELL-1 polypeptide and … [Read more…]

U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels

Label updates reflect growing body of real-world evidence and regulatory confidence in the safety profile of the class of CD19- and BCMA-directed autologous CAR T cell therapies, reinforcing efforts to increase equitable access Only about 2 in 10 eligible patients currently receive cell therapy treatment; today’s announcement will reduce unnecessary barriers for patients and providers … [Read more…]

Lighting the Way: CERTUS Institute and Healthe® Collaborate to Explore How Light Can Improve Life for People with Dementia

ORLANDO, Fla.–(BUSINESS WIRE)–Light isn’t just illumination; it’s innovation in dementia care. That belief drives the CERTUS Institute’s partnership with Healthe® Lighting and the National Institute for Dementia Education (NIDE) to explore how thoughtfully engineered lighting can calm, guide, and restore individuals living with dementia. Together, the partners launched an innovative service-improvement project focused on circadian … [Read more…]